Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Asociación para Evitar la Ceguera en México

Status and phase: Withdrawn; Phase 3

Conditions: Cystoid Macular Edema

Treatments: Drug: Bevacizumab

Study type: Interventional

Funder types: Other

Identifiers

NCT00406172

APEC 0016

Details and patient eligibility

About

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pseudophakic eyes with macular edema

Exclusion criteria

• Other retinopathies